clarithromycin has been researched along with Orbital Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiesewetter, B; Kuchar, A; Lukas, J; Mayerhoefer, ME; Müllauer, L; Raderer, M | 1 |
| Cheng, AL; Huang, HC; Kuo, SH; Lin, CW | 1 |
2 other study(ies) available for clarithromycin and Orbital Neoplasms
| Article | Year |
|---|---|
Clarithromycin Leading to Complete Remission in the First-Line Treatment of Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Clarithromycin; Drug Administration Schedule; Female; Humans; Immunohistochemistry; Induction Chemotherapy; Lacrimal Apparatus; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Neoplasm Staging; Orbital Neoplasms; Remission Induction; Thyroiditis, Autoimmune | 2015 |
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clarithromycin; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Humans; Immunophenotyping; Immunosuppressive Agents; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone Hemisuccinate; Orbital Neoplasms; Prednisolone; Remission Induction; Rituximab; Vincristine | 2013 |